These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17052188)

  • 1. Gankyrin, the 26 S proteasome, the cell cycle and cancer.
    Mayer RJ; Fujita J
    Biochem Soc Trans; 2006 Nov; 34(Pt 5):746-8. PubMed ID: 17052188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gankyrin: a new oncoprotein and regulator of pRb and p53.
    Dawson S; Higashitsuji H; Wilkinson AJ; Fujita J; Mayer RJ
    Trends Cell Biol; 2006 May; 16(5):229-33. PubMed ID: 16581249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas.
    Higashitsuji H; Itoh K; Nagao T; Dawson S; Nonoguchi K; Kido T; Mayer RJ; Arii S; Fujita J
    Nat Med; 2000 Jan; 6(1):96-9. PubMed ID: 10613832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The oncoprotein gankyrin negatively regulates both p53 and RB by enhancing proteasomal degradation.
    Higashitsuji H; Liu Y; Mayer RJ; Fujita J
    Cell Cycle; 2005 Oct; 4(10):1335-7. PubMed ID: 16177571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53.
    Higashitsuji H; Higashitsuji H; Itoh K; Sakurai T; Nagao T; Sumitomo Y; Masuda T; Dawson S; Shimada Y; Mayer RJ; Fujita J
    Cancer Cell; 2005 Jul; 8(1):75-87. PubMed ID: 16023600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of the oncoprotein gankyrin in complex with S6 ATPase of the 26S proteasome.
    Nakamura Y; Nakano K; Umehara T; Kimura M; Hayashizaki Y; Tanaka A; Horikoshi M; Padmanabhan B; Yokoyama S
    Structure; 2007 Feb; 15(2):179-89. PubMed ID: 17292836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoblastoma protein modulates gankyrin-MDM2 in regulation of p53 stability and chemosensitivity in cancer cells.
    Qiu W; Wu J; Walsh EM; Zhang Y; Chen CY; Fujita J; Xiao ZX
    Oncogene; 2008 Jul; 27(29):4034-43. PubMed ID: 18332869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gankyrin promotes the proliferation of human pancreatic cancer.
    Meng Y; He L; Guo X; Tang S; Zhao X; Du R; Jin J; Bi Q; Li H; Nie Y; Liu J; Fan D
    Cancer Lett; 2010 Nov; 297(1):9-17. PubMed ID: 20483533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The crystal structure of gankyrin, an oncoprotein found in complexes with cyclin-dependent kinase 4, a 19 S proteasomal ATPase regulator, and the tumor suppressors Rb and p53.
    Krzywda S; Brzozowski AM; Higashitsuji H; Fujita J; Welchman R; Dawson S; Mayer RJ; Wilkinson AJ
    J Biol Chem; 2004 Jan; 279(2):1541-5. PubMed ID: 14573599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gankyrin: an intriguing name for a novel regulator of p53 and RB.
    Lozano G; Zambetti GP
    Cancer Cell; 2005 Jul; 8(1):3-4. PubMed ID: 16023592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteasomal interactors control activities as diverse as the cell cycle and glutaminergic neurotransmission.
    Rezvani K; Mee M; Dawson S; McIlhinney J; Fujita J; Mayer RJ
    Biochem Soc Trans; 2003 Apr; 31(2):470-3. PubMed ID: 12653665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of gankyrin protein expression with early clinical stages and insulin-like growth factor-binding protein 5 expression in human hepatocellular carcinoma.
    Umemura A; Itoh Y; Itoh K; Yamaguchi K; Nakajima T; Higashitsuji H; Onoue H; Fukumoto M; Okanoue T; Fujita J
    Hepatology; 2008 Feb; 47(2):493-502. PubMed ID: 18161051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of a novel oncogenic protein, gankyrin, in hepatocyte proliferation.
    Iwai A; Marusawa H; Kiuchi T; Higashitsuji H; Tanaka K; Fujita J; Chiba T
    J Gastroenterol; 2003; 38(8):751-8. PubMed ID: 14505129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic Proteins Potently and Selectively Bind the Oncoprotein Gankyrin, Modulate Its Interaction with S6 ATPase, and Suppress Gankyrin/MDM2-Dependent Ubiquitination of p53.
    Chapman AM; McNaughton BR
    ACS Chem Biol; 2015 Aug; 10(8):1880-6. PubMed ID: 25955581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the oncoprotein gankyrin and phosphorylated retinoblastoma protein in human testis and testicular germ cell tumor.
    Ando S; Matsuoka T; Kawai K; Sugita S; Joraku A; Kojima T; Suetomi T; Miyazaki J; Fujita J; Nishiyama H
    Int J Urol; 2014 Oct; 21(10):992-8. PubMed ID: 24861729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of HURP inhibits the proliferation of hepacellular carcinoma cells via downregulation of gankyrin and accumulation of p53.
    Kuo TC; Chang PY; Huang SF; Chou CK; Chao CC
    Biochem Pharmacol; 2012 Mar; 83(6):758-68. PubMed ID: 22230478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for the recognition between the regulatory particles Nas6 and Rpt3 of the yeast 26S proteasome.
    Nakamura Y; Umehara T; Tanaka A; Horikoshi M; Padmanabhan B; Yokoyama S
    Biochem Biophys Res Commun; 2007 Aug; 359(3):503-9. PubMed ID: 17555716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterization of human oncoprotein gankyrin in Zebrafish.
    Kim SY; Hur W; Choi JE; Kim D; Wang JS; Yoon HY; Piao LS; Yoon SK
    Exp Mol Med; 2009 Jan; 41(1):8-16. PubMed ID: 19287195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting retinoblastoma protein for degradation by proteasomes.
    Ying H; Xiao ZX
    Cell Cycle; 2006 Mar; 5(5):506-8. PubMed ID: 16552188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of the homolog of the oncoprotein gankyrin, an interactor of Rb and CDK4/6.
    Padmanabhan B; Adachi N; Kataoka K; Horikoshi M
    J Biol Chem; 2004 Jan; 279(2):1546-52. PubMed ID: 14583612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.